Ftse Mib
34.705,06
0,14%
DAX
18.736,38
-0,11%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
62.521,00
1,75%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Qualigen Therapeutics Inc (QLGN) Qualigen Therapeutics Inc (QLGN) Notizie

Qualigen Therapeutics Inc

QLGN
0,284499
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/5/202402:59EDGAR2Form S-1/A - General form for registration of securities..
16/4/202413:00GLOBEMarizyme Enters Into Co-Development Agreement With Qualigen..
10/4/202414:00GLOBEQualigen Therapeutics' Novel Direct Pan-RAS Inhibitors..
09/4/202414:00GLOBEQualigen Therapeutics Announces Poster Featuring Positive..
27/2/202413:00EDGAR2Form 8-K - Current report
22/2/202422:10EDGAR2Form 8-K - Current report
07/12/202322:15EDGAR2Form 8-K - Current report
22/11/202322:30EDGAR2Form 8-K - Current report
14/11/202322:30GLOBEQualigen Therapeutics Provides Corporate Update for Third..
08/11/202320:16EDGAR2Form 8-K - Current report
07/11/202314:30GLOBEQualigen Therapeutics Announces First Patient Dosed in the..
23/10/202314:30GLOBEPoster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor..
17/10/202314:30EDGAR2Form 8-K - Current report
28/9/202322:15EDGAR2Form 8-K - Current report
27/9/202314:30GLOBEQualigen Therapeutics Presents Scientific Data on QN-302 at..
08/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
01/9/202322:15EDGAR2Form POS AM - Post-Effective amendments for registration..
17/8/202314:30GLOBEQualigen Therapeutics Partners with TD2 for Phase 1 Clinical..
15/8/202316:04EDGAR2Form 8-K - Current report
15/8/202314:30GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..
14/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202322:30EDGAR2Form 8-K - Current report
01/8/202314:35EDGAR2Form 8-K - Current report
01/8/202314:30GLOBEQualigen Therapeutics Announces US FDA IND Clearance to..
26/7/202323:25EDGAR2Form 8-K - Current report
24/7/202314:15GLOBEQualigen Therapeutics Divests FastPack® Diagnostics Business
13/7/202323:29EDGAR2Form 8-K - Current report
07/7/202323:08EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
05/6/202314:15GLOBEPoster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor..
16/5/202314:00GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..
Apertura: Min: Max:
Chiusura: 0,284499

La tua Cronologia

NASDAQ
QLGN
Qualigen Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network